Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01331304 · ClinicalTrials.gov registry record · Phase 4
Comparative Effectiveness Study for Bipolar Disorder
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 482
- Enrollment target
NCT01331304: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT01331304 is a Phase 4 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 482 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01331304, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 482 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of lithium and quetiapine for the treatment of individuals with bipolar disorder.
Interventions
- DRUG Lithium
- DRUG Quetiapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 482 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01331304
The ClinicalTrials.gov registry entry for NCT01331304 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 482 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lithium is the first listed.
NCT01331304 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01331304 about?
NCT01331304 is a clinical study titled "Comparative Effectiveness Study for Bipolar Disorder". The purpose of this study is to compare the effectiveness of lithium and quetiapine for the treatment of individuals with bipolar disorder.
What is the current status of trial NCT01331304?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 482 participants. The study started on 2010-09. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01331304?
The interventions under investigation include: Lithium (DRUG), Quetiapine (DRUG).
Who is sponsoring clinical trial NCT01331304?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.